Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia

Circulation

Volumn 102, Issue 8, 2000, Pages 915-920

  Jeremias, I ^a,c   Kupatt, C ^d   Martin Villalba, A ^b   Habazettl, H ^d   Schenkel, J ^b   Boekstegers, P ^d   Debatin, Klaus Michael ^a,c,e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b II Institute of Physiology   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Apoptosis; Genes; Ischemia; Reperfusion

Indexed keywords

CYTOKINE; FAS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HYPOXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0034702911     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.8.915     Document Type: Article

References (29)

1. Reperfusion induced injury: Manifestations, mechanisms, and clinical relevance
2. Ionic basis of ischaemic cardiac injury: Insights from cellular studies
3. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
4. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
5. Apoptosis in human acute myocardial infarction
6. CD95-ligand (Fas-L/apo-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
7. Apoptosis by death factor
8. Cell death: TRAIL and its receptors
9. Tumor necrosis factor in the heart
10. Metalloproteinase-mediated release of human Fas ligand
11. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage
12. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
13. Apoptosis: Basic mechanisms and implications for cardiovascular disease
14. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
15. Apoptosis in the heart
16. Modes of myocardial cell injury and cell death in ischemic heart disease
17. Ischemic preconditioning decreases apoptosis in rat hearts in vivo
18. Preconditioning in rabbit cardiomyocytes
19. Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts
20. TRAIL/apo-2-ligand-induced apoptosis in human T-cells
21. Nitric oxide mitigates leukocyte adhesion and vascular leak after myocardial ischemia
22. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart
23. Protection of rat cardiomyocytes against simulated ischemia and reoxygenation by treatment with protein kinase C activator
24. Fas and Fas ligand: lpr and gld mutations
25. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol
26. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
27. 2+, and apoptosis in neonatal cardiomyocytes during metabolic inhibition/recovery
28. Cell death attenuation by 'ursurpin,' a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, apo-1) receptor complex
29. Involvement of the CD95 (apo-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells